Document Detail


Coagulase-negative staphylococcal infections in a neonatal intensive care unit: In vivo response to cloxacillin.
MedLine Citation:
PMID:  19030249     Owner:  NLM     Status:  PubMed-not-MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Following the introduction of cloxacillin and gentamicin as the first line of treatment for possible late-onset sepsis (LOS) in the authors' neonatal intensive care unit (NICU), it was subsequently noted that very low birth weight (VLBW) infants improved clinically, despite subsequently positive blood cultures for oxacillin-resistant, coagulase-negative Staphylococcus (CONS). The results of the management of VLBW infants with CONS sepsis during one calendar year, based on clinical rather than laboratory findings, are presented.
METHODS: VLBW infants with LOS were identified through the neonatal database, and the charts of those with CONS were reviewed for antibiotic usage, antibiotic resistance pattern, clearance of CONS from the blood and NICU discharge status. Oxacillin sensitivity was determined by the presence of the mecA gene.
RESULTS: From January 1 to December 31, 2002, 27 VLBW infants, treated in the authors' NICU for LOS due to CONS, were identified. The mean age of LOS infants with CONS was 15 days (median 12 days; range three to 54 days), the mean birth weight (+/- SD) was 904+/-247 g, and the mean gestational age at birth (+/- SD) was 27+/-2 weeks. All infants were started on cloxacillin and gentamicin, and improved clinically over the first 48 h. Six isolates were sensitive to cloxacillin. Twenty-three infants grew oxacillin-resistant CONS, eight of whom had persistence of CONS on repeat culture secondary to central lines. Two infants grew two strains of CONS. Eighteen of 22 infants (82%) with in vitro oxacillin-resistant CONS had clearance of bacteremia with cloxacillin and gentamicin. Ten infants (37%) received vancomycin, based on the authors' guidelines. There were no cases of prolonged bacteremia requiring rifampicin. Three infants died, but none of the deaths could be attributed to CONS.
DISCUSSION: The authors describe clinical improvement with clearance of CONS using cloxacillin and gentamicin, despite laboratory results suggesting oxacillin resistance. The authors' unit policy was based on clinical response and permitted the continuation of cloxacillin, provided that a repeat blood culture was negative. Vancomycin use was suggested for clinical deterioration or persistence of CONS. These results question the in vitro tests of resistance. Clearance of oxacillin-resistant CONS from the blood points to in vivo sensitivity, while the laboratory testing suggests in vitro resistance. The absence of subsequent positive blood cultures for CONS confirms clearance of this organism.
CONCLUSION: It was demonstrated that cloxacillin (150 mg/kg/day dose), along with gentamicin, can clear CONS from the blood within 48 h. The relationship between in vivo and in vitro sensitivities also needs to be further studied both in the laboratory and in a prospective trial.
Authors:
Marc P Blayney; Mahmud Al Madani
Related Documents :
8399899 - Perinatal transmission of ureaplasma urealyticum: current concepts based on review of t...
375179 - Immunofluorescence in group b streptococcal infection and idiopathic respiratory distre...
17903309 - Bench-to-bedside review: developmental influences on the mechanisms, treatment and outc...
8620909 - Carriage of multiple ribotypes of non-encapsulated haemophilus influenzae in aboriginal...
8940229 - Mechanism of antibody-mediated reduction of nasopharyngeal colonization by haemophilus ...
10678719 - Infants colonized with enterotoxin-producing staphylococci at 3 months display a decrea...
20817069 - Developmental consequences and biological significance of mother-infant bonding.
2240119 - The associated anomalies that determine prognosis in congenital omphaloceles.
1186189 - Weight control for high school wrestlers.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Paediatrics & child health     Volume:  11     ISSN:  1205-7088     ISO Abbreviation:  Paediatr Child Health     Publication Date:  2006 Dec 
Date Detail:
Created Date:  2008-11-25     Completed Date:  2011-07-14     Revised Date:  2013-05-23    
Medline Journal Info:
Nlm Unique ID:  9815960     Medline TA:  Paediatr Child Health     Country:  Canada    
Other Details:
Languages:  eng     Pagination:  659-63     Citation Subset:  -    
Affiliation:
Division of Newborn Care, Department of Obstetrics, Ottawa Hospital - General Campus, University of Ottawa, Ottawa, Ontario.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Medical emergencies in children of orthodox Jehovah's Witness families: Three recent legal cases, et...
Next Document:  Evidence-based medicine and the anecdote: Uneasy bedfellows or ideal couple?